Population nutrikinetics of green tea extract
- PMID: 29466429
- PMCID: PMC5821365
- DOI: 10.1371/journal.pone.0193074
Population nutrikinetics of green tea extract
Abstract
Green tea polyphenols may contribute to the prevention of cancer and other diseases. To learn more about the pharmacokinetics and interindividual variation of green tea polyphenols after oral intake in humans we performed a population nutrikinetic study of standardized green tea extract. 84 healthy participants took green tea extract capsules standardized to 150 mg epigallocatechin-gallate (EGCG) twice a day for 5 days. On day 5 catechin plasma concentrations were analyzed using non-compartmental and population pharmacokinetic methods. A strong between-subject variability in catechin pharmacokinetics was found with maximum plasma concentrations varying more than 6-fold. The AUCs of EGCG, EGC and ECG were 877.9 (360.8-1576.5), 35.1 (8.0-87.4), and 183.6 (55.5-364.6) h*μg/L respectively, and the elimination half lives were 2.6 (1.8-3.8), 3.9 (0.9-10.7) and 1.8 (0.8-2.9) h, respectively. Genetic polymorphisms in genes of the drug transporters MRP2 and OATP1B1 could at least partly explain the high variability in pharmacokinetic parameters. The observed variability in catechin plasma levels might contribute to interindividual variation in benefical and adverse effects of green tea polyphenols. Our data could help to gain a better understanding of the causes of variability of green tea effects and to improve the design of studies on the effects of green tea polyphenols in different health conditions.
Trial registration: ClinicalTrials.gov: NCT01360320.
Conflict of interest statement
Figures
References
-
- Balentine DA, Wiseman SA, Bouwens LC (1997) The chemistry of tea flavonoids. Crit Rev Food Sci Nutr 37: 693–704. doi: 10.1080/10408399709527797 - DOI - PubMed
-
- Johnson R, Bryant S, Huntley AL (2012) Green tea and green tea catechin extracts: an overview of the clinical evidence. Maturitas 73: 280–287. doi: 10.1016/j.maturitas.2012.08.008 - DOI - PubMed
-
- Yuan JM (2013) Cancer prevention by green tea: evidence from epidemiologic studies. Am J Clin Nutr 98: 1676S–1681S. doi: 10.3945/ajcn.113.058271 - DOI - PMC - PubMed
-
- Rahmani AH, Al Shabrmi FM, Allemailem KS, Aly SM, Khan MA (2015) Implications of Green Tea and Its Constituents in the Prevention of Cancer via the Modulation of Cell Signalling Pathway. Biomed Res Int 2015: 925640 doi: 10.1155/2015/925640 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
